XML 23 R12.htm IDEA: XBRL DOCUMENT
v3.22.2

Balance Sheet Components | 6 Months Ended
--- | ---
Jun. 30, 2022
Balance Sheet Components |
Balance Sheet Components | 6. Balance Sheet Components ​ Property and Equipment, net ​ The Company’s property and equipment consisted of the following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | June 30, | ​ | December 31,
​ | Useful Life | 2022 |  | 2021
​ | ​ | (in thousands)
Machinery and equipment | 3-5 years | $ | 54,265 | ​ | $ | 33,722
Computer equipment | 3 years | ​ | 1,138 | ​ |  | 4,893
Capitalized software held for internal use | 3 years | ​ | 3,112 | ​ | ​ | 2,395
Leasehold improvements | Lesser of useful life or lease term | ​ | 27,814 | ​ |  | 13,640
Construction-in-process | ​ | ​ | 22,000 | ​ |  | 30,279
​ | ​ | ​ | 108,329 | ​ |  | 84,929
Less: Accumulated depreciation and amortization | ​ | ​ | (26,557) | ​ |  | (19,413)
Total Property and Equipment, net | ​ | $ | 81,772 | ​ | $ | 65,516
​ The Company’s long-lived assets are primarily located in the United States. ​ During the six months ended June 30, 2022, the increase in net property and equipment was due to purchases of new equipment for the Company’s laboratories located in Texas and California to expand testing capabilities, offset by depreciation expense of $7.3 million recorded in the six months ended June 30, 2022 compared to depreciation expense of $5.3 million recorded in the six months ended June 30, 2021. The Company did not incur an impairment charge during the six months ended June 30, 2022 or June 30, 2021. ​ Accrued Compensation ​ The Company’s accrued compensation consisted of the following: ​
​ | ​ | ​ | ​ | ​ | ​
​ | June 30, |  | December 31,
​ | 2022 |  | 2021
​ | (in thousands)
Accrued paid time off | $ | 2,930 | ​ | $ | 2,567
Accrued commissions |  | 12,454 | ​ |  | 15,726
Accrued bonuses |  | 11,324 | ​ |  | 15,854
Other accrued compensation |  | 6,251 | ​ |  | 6,794
Total accrued compensation | $ | 32,959 | ​ | $ | 40,941
​ Other Accrued Liabilities ​ The Company’s other accrued liabilities consisted of the following: ​
​ | ​ | ​ | ​ | ​ | ​
​ | June 30, |  | December 31,
​ | 2022 |  | 2021
​ | (in thousands)
Reserves for refunds to insurance carriers | $ | 15,912 | ​ | $ | 17,210
Accrued charges for third-party testing | ​ | 23,142 | ​ | ​ | 5,849
Testing and laboratory materials from suppliers | ​ | 13,997 | ​ | ​ | 3,799
Marketing and corporate affairs | ​ | 6,449 | ​ | ​ | 7,853
Legal, audit and consulting fees | ​ | 21,374 | ​ |  | 11,758
Accrued shipping charges | ​ | 2,157 | ​ | ​ | 969
Sales tax payable | ​ | 1,857 | ​ | ​ | 2,230
Accrued third-party service fees | ​ | 1,354 | ​ | ​ | 13,442
Clinical trials and studies |  | 21,166 | ​ | ​ | 11,218
Operating lease liabilities, current portion | ​ | 5,636 | ​ | ​ | 5,752
Fixed asset purchases | ​ | 5,608 | ​ | ​ | 1,853
Other accrued interest | ​ | 1,078 | ​ | ​ | 1,078
Other accrued expenses |  | 4,642 | ​ | ​ | 10,342
Total other accrued liabilities | $ | 124,372 | ​ | $ | 93,353
​ Reserves for refunds to insurance carriers include overpayments from and amounts to be refunded to insurance carriers, and additional amounts that the Company estimates for potential refund requests during the period. When the Company releases these previously accrued amounts, they are recognized as product revenues in the condensed statements of operations and comprehensive loss. ​ The following table summarizes the reserve balance and activities for refunds to insurance carriers for the six months ended June 30, 2022 or June 30, 2021: ​
​ | ​ | ​ | ​ | ​ | ​
​ | June 30, |  | June 30,
​ | 2022 |  | 2021
​ | (in thousands)
Beginning balance | $ | 17,210 | ​ | $ | 17,366
Additional reserves |  | 8,576 | ​ |  | 10,960
Refunds to carriers |  | (6,491) | ​ | ​ | (3,054)
Reserves released to revenue | ​ | (3,383) | ​ | ​ | (2,971)
Ending balance | $ | 15,912 | ​ | $ | 22,301
​ | ​ | ​ | ​ | ​ | ​
​

X
- References No definition available. + Details
Name: | us-gaap_BalanceSheetRelatedDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -URI http://asc.fasb.org/topic&trid=2122208 + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration